Media

ConvaTec Signs New National Agreements with Vizient, Inc.

3. maj 2016

Three new agreements awarded for stoma care, bowel management and patient skin care categories

LUXEMBOURG (May 3, 2016) — ConvaTec today announced that it has finalized three new national agreements with Vizient, Inc. for Stoma Care, Bowel Management and Patient Skin Care. ConvaTec is a leading global medical products and technologies company; Vizient is the largest member-owned health care company in the U.S. 

All three agreements will be effective starting July 1, 2016 for a period of three years for Vizient members currently accessing the legacy Novation contract portfolio.

“At ConvaTec, we exist to improve the lives of the people we touch, many of whom rely on us to help them lead a more normal life,” said Tim Moran, President, Americas at ConvaTec. “We’re proud to continue our long-standing relationship with Vizient. These new agreements demonstrate our commitment to meeting patients’ needs with advanced technologies and best-in-class products and services in these three important areas of healthcare.”

About ConvaTec

ConvaTec is a global medical products and technologies company with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. ConvaTec’s products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. The company is owned by Nordic Capital and Avista Capital Partners. More information is available at www.convatec.com.

# # #

®/™ indicates trademarks of ConvaTec Inc.
© 2016 ConvaTec Inc.
AP-016407-US

 

 

Download PRESS RELEASE

 

 

 

 

Cookies er nødvendige for at få denne hjemmesiden til at virke optimalt. De hjælper os til at vide lidt om, hvordan du bruger vores hjemmeside,  hvilket forbedrer brugeroplevelsen både for dig og for andre. Cookies på dette site anvendes kun til trafikmåling og optimering af sidens indhold. Hvis du fortsætter med at anvende denne hjemmeside, accepterer du brugen af ​​cookies. Du kan blokere for brugen af cookies ved at følge instruktionen Sådan blokeres og undgås cookies

Lær mere om vores cookie politik